REG - FIL Limited Covidien plc Medtronic, Inc. - Form 8.3 - [Covidien Plc] <Origin Href="QuoteRef">COV.N</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
RNS Number : 0295TFIL Limited30 September 2014FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2007 (AS AMENDED)DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE1. KEY INFORMATION
Name of person dealing (Note 1)
FMR LLC and/or one or more of its direct or indirect subsidiaries
And
FIL Limited and/or one or more of its direct and indirect subsidiaries
Company dealt in
COVIDIEN PLC
Class of relevant security to which the dealings being disclosed relate(Note 2)
Ordinary shares
Date of dealing
29-September-14
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security
dealt in(Note 3)
Long
Short
Number (%)
Number (%)
(1) Relevant securities
19,801,068 4.45
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
19,801,068 4.45
b) Interests and short positions in relevant securities of the company, other than the
class dealt in(Note 3)
Class of relevant security:
Long
Short
Number (%)
Number (%)
(91) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
3. DEALINGS(Note 4)
(91) Purchases and sales
Purchase/sale
Number of securities
Price per unit
Sale
35
88.65 USD/ Share
Sale
171
88.18 USD/ Share
Sale
300
88.245 USD/ Share
Sale
530
88.5069 USD/ Share
Sale
1,400
88.0489 USD/ Share
Sale
2,207
88.6108 USD/ Share
Sale
2,400
88.3238 USD/ Share
Sale
3,500
88.1557 USD/ Share
Sale
4,780
88.229 USD/ Share
Sale
5,000
88.225 USD/ Share
Sale
5,400
88.512 USD/ Share
Sale
6,347
88.157 USD/ Share
Sale
13,712
88.1219 USD/ Share
Sale
17,324
88.4755 USD/ Share
Sale
18,300
88.432 USD/ Share
Sale
20,000
88.2125 USD/ Share
Sale
20,114
88.2224 USD/ Share
Sale
21,254
88.5571 USD/ Share
Sale
45,937
88.5449 USD/ Share
Sale
54,153
88.213 USD/ Share
Sale
86,536
87.8387 USD/ Share
Buy
14
87.81 USD/ Share
Buy
4
90.00 USD/ Share
Sale
3
90.09 USD/ Share
Buy
29
90.13 USD/ Share
Sale
18
90.12 USD/ Share
Buy
36
90.10 USD/ Share
(b) Derivatives transactions (other than options transactions)
Product name,
e.g. CFD
Nature of transaction (Note 6)
Number of securities (Note 7)
Price per unit (Note 5)
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name,
e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise
price
Type, e.g. American, European etc.
Expiry
date
Option money
paid/received per unit (Note 5)
(ii) Exercising
Product name, e.g. call option
Number of securities
Exercise price per unit (Note 5)
(d) Other dealings (including transactions in respect of new securities)(Note 4)
Nature of transaction (Note 8)
Details
Price per unit (if applicable)(Note 5)
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Is a Supplemental Form 8 attached?(Note 9)NO
Date of disclosure
30 September 2014
Contact name
Nina Collomosse
Telephone number
+44 (0)1737 837092
If a connected EFM, name of offeree/offeror with which connected
N/A
If a connected EFM, state nature of connection (Note 10)
N/A
This information is provided by RNSThe company news service from the London Stock ExchangeENDISEBDGDCXUXBGSG
Recent news on Medtronic
See all newsRCS - Cydar Ltd - First patient treated in Medtronic collaboration
AnnouncementRCS - Cydar Ltd - Kenneth Hitchner appointed Cydar Medical Chairman
AnnouncementRCS - Cydar Ltd - Cydar Medical raises $11.5m (£9.3m) in Series A
AnnouncementREG - Baillie GiffordJapan - Net Asset Value(s) <Origin Href="QuoteRef">BGFD.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
AnnouncementREG - Goldman Sachs (EPT) Greene King PLC - Form 8.5 (EPT/RI) - Amendment <Origin Href="QuoteRef">GNK.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
Announcement